Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C

Circ Res. 2002 Jul 26;91(2):112-9. doi: 10.1161/01.res.0000026057.13161.42.

Abstract

Although recent investigations have suggested that a Rho-kinase-mediated Ca2+ sensitization of vascular smooth muscle contraction plays a critical role in the pathogenesis of cerebral and coronary vasospasm, the upstream of this signal transduction has not been elucidated. In addition, the involvement of protein kinase C (PKC) may also be related to cerebral vasospasm. We recently reported that sphingosylphosphorylcholine (SPC), a sphingolipid, induces Rho-kinase-mediated Ca2+ sensitization in pig coronary arteries. The purpose of this present study was to examine the possible mediation of SPC in Ca2+ sensitization of the bovine middle cerebral artery (MCA) and the relation to signal transduction pathways mediated by Rho-kinase and PKC. In intact MCA, SPC induced a concentration-dependent (EC50=3.0 micromol/L) contraction, without [Ca2+]i elevation. In membrane-permeabilized MCA, SPC induced Ca2+ sensitization even in the absence of added GTP, which is required for activation of G-proteins coupled to membrane receptors. The SPC-induced Ca2+ sensitization was blocked by a Rho-kinase inhibitor (Y-27632) and a dominant-negative Rho-kinase, but not by a pseudosubstrate peptide for conventional PKC, which abolished the Ca2+-independent contraction induced by phorbol ester. In contrast, phorbol ester-induced Ca2+ sensitization was resistant to a Rho-kinase inhibitor and a dominant-negative Rho-kinase. In primary cultured vascular smooth muscle cells, SPC induced the translocation of cytosolic Rho-kinase to the cell membrane. We propose that SPC is a novel messenger for Rho-kinase-mediated Ca2+ sensitization of cerebral arterial smooth muscle and, therefore, may play a pivotal role in the pathogenesis of abnormal contraction of the cerebral artery such as vasospasm. The SPC/Rho-kinase pathway functions independently of the PKC pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Signaling*
  • Cattle
  • Cell Membrane / enzymology
  • Cell Membrane Permeability / drug effects
  • Cells, Cultured
  • Cerebral Arteries / drug effects
  • Cerebral Arteries / enzymology
  • Cerebral Arteries / metabolism*
  • Cerebral Arteries / physiology
  • Culture Techniques
  • Enzyme Inhibitors / pharmacology
  • Escin / pharmacology
  • GTP-Binding Proteins / physiology
  • Intracellular Signaling Peptides and Proteins
  • Kinetics
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / pharmacology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology*
  • Protein Serine-Threonine Kinases / analysis
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology*
  • rho-Associated Kinases

Substances

  • Enzyme Inhibitors
  • Intracellular Signaling Peptides and Proteins
  • sphingosine phosphorylcholine
  • Phosphorylcholine
  • Phorbol 12,13-Dibutyrate
  • Escin
  • Protein Serine-Threonine Kinases
  • rho-Associated Kinases
  • Protein Kinase C
  • GTP-Binding Proteins
  • Sphingosine